nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—PTGIS—blood vessel—stomach cancer	0.0271	0.129	CbGeAlD
Epoprostenol—PTGIS—gall bladder—stomach cancer	0.0255	0.122	CbGeAlD
Epoprostenol—PTGIR—blood vessel—stomach cancer	0.0156	0.0742	CbGeAlD
Epoprostenol—P2RY12—hematopoietic system—stomach cancer	0.013	0.062	CbGeAlD
Epoprostenol—PTGIS—smooth muscle tissue—stomach cancer	0.0127	0.0606	CbGeAlD
Epoprostenol—P2RY12—epithelium—stomach cancer	0.0119	0.0567	CbGeAlD
Epoprostenol—PTGER1—pancreas—stomach cancer	0.0109	0.0521	CbGeAlD
Epoprostenol—Bimatoprost—AKR1C3—stomach cancer	0.00848	1	CrCbGaD
Epoprostenol—PTGIS—endocrine gland—stomach cancer	0.00829	0.0396	CbGeAlD
Epoprostenol—PTGIR—hematopoietic system—stomach cancer	0.00829	0.0395	CbGeAlD
Epoprostenol—PTGER1—endocrine gland—stomach cancer	0.00771	0.0368	CbGeAlD
Epoprostenol—PTGIR—epithelium—stomach cancer	0.00758	0.0361	CbGeAlD
Epoprostenol—PTGIS—liver—stomach cancer	0.00748	0.0357	CbGeAlD
Epoprostenol—P2RY12—endocrine gland—stomach cancer	0.00747	0.0356	CbGeAlD
Epoprostenol—PTGIR—smooth muscle tissue—stomach cancer	0.0073	0.0348	CbGeAlD
Epoprostenol—PTGIR—pancreas—stomach cancer	0.00675	0.0322	CbGeAlD
Epoprostenol—PTGIR—digestive system—stomach cancer	0.00576	0.0275	CbGeAlD
Epoprostenol—PTGIS—lymph node—stomach cancer	0.00573	0.0273	CbGeAlD
Epoprostenol—PTGIR—endocrine gland—stomach cancer	0.00476	0.0227	CbGeAlD
Epoprostenol—PTGIR—liver—stomach cancer	0.00429	0.0205	CbGeAlD
Epoprostenol—PTGIR—lymph node—stomach cancer	0.00329	0.0157	CbGeAlD
Epoprostenol—CYP2C9—hematopoietic system—stomach cancer	0.00296	0.0141	CbGeAlD
Epoprostenol—CYP2C9—digestive system—stomach cancer	0.00206	0.00982	CbGeAlD
Epoprostenol—CYP2C9—endocrine gland—stomach cancer	0.0017	0.00812	CbGeAlD
Epoprostenol—CYP2C9—liver—stomach cancer	0.00153	0.00732	CbGeAlD
Epoprostenol—Nervous system disorder—Capecitabine—stomach cancer	0.000421	0.000911	CcSEcCtD
Epoprostenol—Haemorrhage—Epirubicin—stomach cancer	0.000421	0.000911	CcSEcCtD
Epoprostenol—Diarrhoea—Fluorouracil—stomach cancer	0.000421	0.00091	CcSEcCtD
Epoprostenol—Thrombocytopenia—Capecitabine—stomach cancer	0.000421	0.00091	CcSEcCtD
Epoprostenol—Tachycardia—Capecitabine—stomach cancer	0.000419	0.000907	CcSEcCtD
Epoprostenol—Hypoaesthesia—Epirubicin—stomach cancer	0.000419	0.000907	CcSEcCtD
Epoprostenol—Pharyngitis—Epirubicin—stomach cancer	0.000418	0.000905	CcSEcCtD
Epoprostenol—Cardiac disorder—Methotrexate—stomach cancer	0.000418	0.000904	CcSEcCtD
Epoprostenol—Skin disorder—Capecitabine—stomach cancer	0.000417	0.000903	CcSEcCtD
Epoprostenol—Sweating—Doxorubicin—stomach cancer	0.000416	0.000901	CcSEcCtD
Epoprostenol—Hyperhidrosis—Capecitabine—stomach cancer	0.000415	0.000899	CcSEcCtD
Epoprostenol—Oedema peripheral—Epirubicin—stomach cancer	0.000415	0.000898	CcSEcCtD
Epoprostenol—Hypotension—Docetaxel—stomach cancer	0.000415	0.000897	CcSEcCtD
Epoprostenol—Haematuria—Doxorubicin—stomach cancer	0.000414	0.000896	CcSEcCtD
Epoprostenol—Connective tissue disorder—Epirubicin—stomach cancer	0.000414	0.000896	CcSEcCtD
Epoprostenol—Epistaxis—Doxorubicin—stomach cancer	0.00041	0.000886	CcSEcCtD
Epoprostenol—Anorexia—Capecitabine—stomach cancer	0.000409	0.000886	CcSEcCtD
Epoprostenol—Angiopathy—Methotrexate—stomach cancer	0.000408	0.000884	CcSEcCtD
Epoprostenol—Vomiting—Irinotecan—stomach cancer	0.000408	0.000883	CcSEcCtD
Epoprostenol—Sinusitis—Doxorubicin—stomach cancer	0.000407	0.000881	CcSEcCtD
Epoprostenol—Dizziness—Fluorouracil—stomach cancer	0.000406	0.00088	CcSEcCtD
Epoprostenol—Mediastinal disorder—Methotrexate—stomach cancer	0.000406	0.000878	CcSEcCtD
Epoprostenol—Rash—Irinotecan—stomach cancer	0.000405	0.000876	CcSEcCtD
Epoprostenol—Dermatitis—Irinotecan—stomach cancer	0.000404	0.000875	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000404	0.000875	CcSEcCtD
Epoprostenol—Chills—Methotrexate—stomach cancer	0.000404	0.000874	CcSEcCtD
Epoprostenol—Headache—Irinotecan—stomach cancer	0.000402	0.00087	CcSEcCtD
Epoprostenol—Hypotension—Capecitabine—stomach cancer	0.000401	0.000869	CcSEcCtD
Epoprostenol—Insomnia—Docetaxel—stomach cancer	0.000401	0.000868	CcSEcCtD
Epoprostenol—Paraesthesia—Docetaxel—stomach cancer	0.000398	0.000862	CcSEcCtD
Epoprostenol—Bradycardia—Doxorubicin—stomach cancer	0.000397	0.000859	CcSEcCtD
Epoprostenol—Dyspnoea—Docetaxel—stomach cancer	0.000396	0.000856	CcSEcCtD
Epoprostenol—Somnolence—Docetaxel—stomach cancer	0.000394	0.000853	CcSEcCtD
Epoprostenol—Mental disorder—Methotrexate—stomach cancer	0.000394	0.000853	CcSEcCtD
Epoprostenol—Haemoglobin—Doxorubicin—stomach cancer	0.000392	0.000848	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000391	0.000847	CcSEcCtD
Epoprostenol—Cardiac disorder—Epirubicin—stomach cancer	0.000391	0.000846	CcSEcCtD
Epoprostenol—Flushing—Epirubicin—stomach cancer	0.000391	0.000846	CcSEcCtD
Epoprostenol—Vomiting—Fluorouracil—stomach cancer	0.000391	0.000846	CcSEcCtD
Epoprostenol—Rhinitis—Doxorubicin—stomach cancer	0.000391	0.000845	CcSEcCtD
Epoprostenol—Dyspepsia—Docetaxel—stomach cancer	0.000391	0.000845	CcSEcCtD
Epoprostenol—Haemorrhage—Doxorubicin—stomach cancer	0.00039	0.000843	CcSEcCtD
Epoprostenol—Insomnia—Capecitabine—stomach cancer	0.000389	0.000841	CcSEcCtD
Epoprostenol—Hypoaesthesia—Doxorubicin—stomach cancer	0.000388	0.000839	CcSEcCtD
Epoprostenol—Rash—Fluorouracil—stomach cancer	0.000388	0.000839	CcSEcCtD
Epoprostenol—Dermatitis—Fluorouracil—stomach cancer	0.000387	0.000838	CcSEcCtD
Epoprostenol—Pharyngitis—Doxorubicin—stomach cancer	0.000387	0.000837	CcSEcCtD
Epoprostenol—Paraesthesia—Capecitabine—stomach cancer	0.000386	0.000835	CcSEcCtD
Epoprostenol—Decreased appetite—Docetaxel—stomach cancer	0.000386	0.000835	CcSEcCtD
Epoprostenol—Headache—Fluorouracil—stomach cancer	0.000385	0.000833	CcSEcCtD
Epoprostenol—Oedema peripheral—Doxorubicin—stomach cancer	0.000384	0.000831	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000383	0.000829	CcSEcCtD
Epoprostenol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000383	0.000829	CcSEcCtD
Epoprostenol—Dyspnoea—Capecitabine—stomach cancer	0.000383	0.000829	CcSEcCtD
Epoprostenol—Fatigue—Docetaxel—stomach cancer	0.000383	0.000828	CcSEcCtD
Epoprostenol—Angiopathy—Epirubicin—stomach cancer	0.000382	0.000827	CcSEcCtD
Epoprostenol—Nausea—Irinotecan—stomach cancer	0.000381	0.000825	CcSEcCtD
Epoprostenol—Mediastinal disorder—Epirubicin—stomach cancer	0.00038	0.000821	CcSEcCtD
Epoprostenol—Pain—Docetaxel—stomach cancer	0.000379	0.000821	CcSEcCtD
Epoprostenol—Constipation—Docetaxel—stomach cancer	0.000379	0.000821	CcSEcCtD
Epoprostenol—Back pain—Methotrexate—stomach cancer	0.000379	0.00082	CcSEcCtD
Epoprostenol—Dyspepsia—Capecitabine—stomach cancer	0.000378	0.000818	CcSEcCtD
Epoprostenol—Chills—Epirubicin—stomach cancer	0.000378	0.000818	CcSEcCtD
Epoprostenol—Decreased appetite—Capecitabine—stomach cancer	0.000373	0.000808	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000371	0.000802	CcSEcCtD
Epoprostenol—Fatigue—Capecitabine—stomach cancer	0.00037	0.000801	CcSEcCtD
Epoprostenol—Mental disorder—Epirubicin—stomach cancer	0.000369	0.000798	CcSEcCtD
Epoprostenol—Constipation—Capecitabine—stomach cancer	0.000367	0.000795	CcSEcCtD
Epoprostenol—Pain—Capecitabine—stomach cancer	0.000367	0.000795	CcSEcCtD
Epoprostenol—Nausea—Fluorouracil—stomach cancer	0.000365	0.00079	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Docetaxel—stomach cancer	0.000363	0.000785	CcSEcCtD
Epoprostenol—Anaemia—Methotrexate—stomach cancer	0.000362	0.000784	CcSEcCtD
Epoprostenol—Flushing—Doxorubicin—stomach cancer	0.000362	0.000783	CcSEcCtD
Epoprostenol—Cardiac disorder—Doxorubicin—stomach cancer	0.000362	0.000783	CcSEcCtD
Epoprostenol—Flatulence—Epirubicin—stomach cancer	0.000361	0.000782	CcSEcCtD
Epoprostenol—Tension—Epirubicin—stomach cancer	0.00036	0.000779	CcSEcCtD
Epoprostenol—Nervousness—Epirubicin—stomach cancer	0.000356	0.000771	CcSEcCtD
Epoprostenol—Back pain—Epirubicin—stomach cancer	0.000355	0.000767	CcSEcCtD
Epoprostenol—Angiopathy—Doxorubicin—stomach cancer	0.000354	0.000765	CcSEcCtD
Epoprostenol—Muscle spasms—Epirubicin—stomach cancer	0.000353	0.000763	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000351	0.00076	CcSEcCtD
Epoprostenol—Mediastinal disorder—Doxorubicin—stomach cancer	0.000351	0.00076	CcSEcCtD
Epoprostenol—Abdominal pain—Docetaxel—stomach cancer	0.000351	0.000759	CcSEcCtD
Epoprostenol—Body temperature increased—Docetaxel—stomach cancer	0.000351	0.000759	CcSEcCtD
Epoprostenol—Chills—Doxorubicin—stomach cancer	0.00035	0.000757	CcSEcCtD
Epoprostenol—Cough—Methotrexate—stomach cancer	0.000342	0.00074	CcSEcCtD
Epoprostenol—Mental disorder—Doxorubicin—stomach cancer	0.000341	0.000739	CcSEcCtD
Epoprostenol—Urticaria—Capecitabine—stomach cancer	0.000341	0.000738	CcSEcCtD
Epoprostenol—Body temperature increased—Capecitabine—stomach cancer	0.00034	0.000735	CcSEcCtD
Epoprostenol—Abdominal pain—Capecitabine—stomach cancer	0.00034	0.000735	CcSEcCtD
Epoprostenol—Anaemia—Epirubicin—stomach cancer	0.000339	0.000733	CcSEcCtD
Epoprostenol—Agitation—Epirubicin—stomach cancer	0.000337	0.000729	CcSEcCtD
Epoprostenol—Flatulence—Doxorubicin—stomach cancer	0.000334	0.000723	CcSEcCtD
Epoprostenol—Chest pain—Methotrexate—stomach cancer	0.000334	0.000722	CcSEcCtD
Epoprostenol—Arthralgia—Methotrexate—stomach cancer	0.000334	0.000722	CcSEcCtD
Epoprostenol—Myalgia—Methotrexate—stomach cancer	0.000334	0.000722	CcSEcCtD
Epoprostenol—Tension—Doxorubicin—stomach cancer	0.000333	0.00072	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000331	0.000717	CcSEcCtD
Epoprostenol—Nervousness—Doxorubicin—stomach cancer	0.00033	0.000713	CcSEcCtD
Epoprostenol—Syncope—Epirubicin—stomach cancer	0.000329	0.000711	CcSEcCtD
Epoprostenol—Back pain—Doxorubicin—stomach cancer	0.000328	0.00071	CcSEcCtD
Epoprostenol—Hypersensitivity—Docetaxel—stomach cancer	0.000327	0.000707	CcSEcCtD
Epoprostenol—Muscle spasms—Doxorubicin—stomach cancer	0.000326	0.000706	CcSEcCtD
Epoprostenol—Palpitations—Epirubicin—stomach cancer	0.000324	0.000701	CcSEcCtD
Epoprostenol—Confusional state—Methotrexate—stomach cancer	0.000322	0.000698	CcSEcCtD
Epoprostenol—Loss of consciousness—Epirubicin—stomach cancer	0.000322	0.000697	CcSEcCtD
Epoprostenol—Cough—Epirubicin—stomach cancer	0.00032	0.000692	CcSEcCtD
Epoprostenol—Anaphylactic shock—Methotrexate—stomach cancer	0.00032	0.000692	CcSEcCtD
Epoprostenol—Asthenia—Docetaxel—stomach cancer	0.000318	0.000689	CcSEcCtD
Epoprostenol—Infection—Methotrexate—stomach cancer	0.000318	0.000687	CcSEcCtD
Epoprostenol—Hypersensitivity—Capecitabine—stomach cancer	0.000316	0.000685	CcSEcCtD
Epoprostenol—Pruritus—Docetaxel—stomach cancer	0.000314	0.000679	CcSEcCtD
Epoprostenol—Nervous system disorder—Methotrexate—stomach cancer	0.000314	0.000679	CcSEcCtD
Epoprostenol—Anaemia—Doxorubicin—stomach cancer	0.000314	0.000679	CcSEcCtD
Epoprostenol—Thrombocytopenia—Methotrexate—stomach cancer	0.000313	0.000677	CcSEcCtD
Epoprostenol—Arthralgia—Epirubicin—stomach cancer	0.000312	0.000675	CcSEcCtD
Epoprostenol—Chest pain—Epirubicin—stomach cancer	0.000312	0.000675	CcSEcCtD
Epoprostenol—Myalgia—Epirubicin—stomach cancer	0.000312	0.000675	CcSEcCtD
Epoprostenol—Agitation—Doxorubicin—stomach cancer	0.000312	0.000675	CcSEcCtD
Epoprostenol—Anxiety—Epirubicin—stomach cancer	0.000311	0.000673	CcSEcCtD
Epoprostenol—Skin disorder—Methotrexate—stomach cancer	0.000311	0.000672	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00031	0.000671	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methotrexate—stomach cancer	0.000309	0.000669	CcSEcCtD
Epoprostenol—Asthenia—Capecitabine—stomach cancer	0.000308	0.000667	CcSEcCtD
Epoprostenol—Dry mouth—Epirubicin—stomach cancer	0.000305	0.000661	CcSEcCtD
Epoprostenol—Anorexia—Methotrexate—stomach cancer	0.000305	0.00066	CcSEcCtD
Epoprostenol—Syncope—Doxorubicin—stomach cancer	0.000304	0.000658	CcSEcCtD
Epoprostenol—Pruritus—Capecitabine—stomach cancer	0.000304	0.000658	CcSEcCtD
Epoprostenol—Diarrhoea—Docetaxel—stomach cancer	0.000304	0.000657	CcSEcCtD
Epoprostenol—Confusional state—Epirubicin—stomach cancer	0.000302	0.000653	CcSEcCtD
Epoprostenol—Palpitations—Doxorubicin—stomach cancer	0.0003	0.000649	CcSEcCtD
Epoprostenol—Anaphylactic shock—Epirubicin—stomach cancer	0.000299	0.000648	CcSEcCtD
Epoprostenol—Oedema—Epirubicin—stomach cancer	0.000299	0.000648	CcSEcCtD
Epoprostenol—Hypotension—Methotrexate—stomach cancer	0.000299	0.000647	CcSEcCtD
Epoprostenol—Loss of consciousness—Doxorubicin—stomach cancer	0.000298	0.000645	CcSEcCtD
Epoprostenol—Infection—Epirubicin—stomach cancer	0.000297	0.000643	CcSEcCtD
Epoprostenol—Cough—Doxorubicin—stomach cancer	0.000296	0.000641	CcSEcCtD
Epoprostenol—Shock—Epirubicin—stomach cancer	0.000294	0.000637	CcSEcCtD
Epoprostenol—Diarrhoea—Capecitabine—stomach cancer	0.000294	0.000636	CcSEcCtD
Epoprostenol—Nervous system disorder—Epirubicin—stomach cancer	0.000293	0.000635	CcSEcCtD
Epoprostenol—Dizziness—Docetaxel—stomach cancer	0.000293	0.000635	CcSEcCtD
Epoprostenol—Thrombocytopenia—Epirubicin—stomach cancer	0.000293	0.000634	CcSEcCtD
Epoprostenol—Tachycardia—Epirubicin—stomach cancer	0.000292	0.000632	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000291	0.00063	CcSEcCtD
Epoprostenol—Skin disorder—Epirubicin—stomach cancer	0.000291	0.000629	CcSEcCtD
Epoprostenol—Hyperhidrosis—Epirubicin—stomach cancer	0.000289	0.000626	CcSEcCtD
Epoprostenol—Insomnia—Methotrexate—stomach cancer	0.000289	0.000626	CcSEcCtD
Epoprostenol—Myalgia—Doxorubicin—stomach cancer	0.000289	0.000625	CcSEcCtD
Epoprostenol—Chest pain—Doxorubicin—stomach cancer	0.000289	0.000625	CcSEcCtD
Epoprostenol—Arthralgia—Doxorubicin—stomach cancer	0.000289	0.000625	CcSEcCtD
Epoprostenol—Anxiety—Doxorubicin—stomach cancer	0.000288	0.000623	CcSEcCtD
Epoprostenol—Paraesthesia—Methotrexate—stomach cancer	0.000287	0.000621	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000287	0.000621	CcSEcCtD
Epoprostenol—Anorexia—Epirubicin—stomach cancer	0.000285	0.000617	CcSEcCtD
Epoprostenol—Dyspnoea—Methotrexate—stomach cancer	0.000285	0.000617	CcSEcCtD
Epoprostenol—Somnolence—Methotrexate—stomach cancer	0.000284	0.000615	CcSEcCtD
Epoprostenol—Dizziness—Capecitabine—stomach cancer	0.000284	0.000615	CcSEcCtD
Epoprostenol—Dry mouth—Doxorubicin—stomach cancer	0.000282	0.000611	CcSEcCtD
Epoprostenol—Vomiting—Docetaxel—stomach cancer	0.000282	0.00061	CcSEcCtD
Epoprostenol—Dyspepsia—Methotrexate—stomach cancer	0.000281	0.000609	CcSEcCtD
Epoprostenol—Rash—Docetaxel—stomach cancer	0.00028	0.000605	CcSEcCtD
Epoprostenol—Hypotension—Epirubicin—stomach cancer	0.00028	0.000605	CcSEcCtD
Epoprostenol—Dermatitis—Docetaxel—stomach cancer	0.000279	0.000605	CcSEcCtD
Epoprostenol—Confusional state—Doxorubicin—stomach cancer	0.000279	0.000604	CcSEcCtD
Epoprostenol—Decreased appetite—Methotrexate—stomach cancer	0.000278	0.000601	CcSEcCtD
Epoprostenol—Headache—Docetaxel—stomach cancer	0.000278	0.000601	CcSEcCtD
Epoprostenol—Anaphylactic shock—Doxorubicin—stomach cancer	0.000277	0.000599	CcSEcCtD
Epoprostenol—Oedema—Doxorubicin—stomach cancer	0.000277	0.000599	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000276	0.000597	CcSEcCtD
Epoprostenol—Fatigue—Methotrexate—stomach cancer	0.000276	0.000597	CcSEcCtD
Epoprostenol—Infection—Doxorubicin—stomach cancer	0.000275	0.000595	CcSEcCtD
Epoprostenol—Pain—Methotrexate—stomach cancer	0.000273	0.000592	CcSEcCtD
Epoprostenol—Vomiting—Capecitabine—stomach cancer	0.000273	0.000591	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000273	0.00059	CcSEcCtD
Epoprostenol—Shock—Doxorubicin—stomach cancer	0.000272	0.000589	CcSEcCtD
Epoprostenol—Nervous system disorder—Doxorubicin—stomach cancer	0.000272	0.000588	CcSEcCtD
Epoprostenol—Thrombocytopenia—Doxorubicin—stomach cancer	0.000271	0.000587	CcSEcCtD
Epoprostenol—Rash—Capecitabine—stomach cancer	0.000271	0.000586	CcSEcCtD
Epoprostenol—Insomnia—Epirubicin—stomach cancer	0.000271	0.000586	CcSEcCtD
Epoprostenol—Dermatitis—Capecitabine—stomach cancer	0.000271	0.000585	CcSEcCtD
Epoprostenol—Tachycardia—Doxorubicin—stomach cancer	0.00027	0.000585	CcSEcCtD
Epoprostenol—Headache—Capecitabine—stomach cancer	0.000269	0.000582	CcSEcCtD
Epoprostenol—Skin disorder—Doxorubicin—stomach cancer	0.000269	0.000582	CcSEcCtD
Epoprostenol—Paraesthesia—Epirubicin—stomach cancer	0.000269	0.000581	CcSEcCtD
Epoprostenol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000268	0.000579	CcSEcCtD
Epoprostenol—Dyspnoea—Epirubicin—stomach cancer	0.000267	0.000577	CcSEcCtD
Epoprostenol—Somnolence—Epirubicin—stomach cancer	0.000266	0.000576	CcSEcCtD
Epoprostenol—Anorexia—Doxorubicin—stomach cancer	0.000264	0.000571	CcSEcCtD
Epoprostenol—Nausea—Docetaxel—stomach cancer	0.000264	0.00057	CcSEcCtD
Epoprostenol—Dyspepsia—Epirubicin—stomach cancer	0.000263	0.00057	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methotrexate—stomach cancer	0.000261	0.000566	CcSEcCtD
Epoprostenol—Decreased appetite—Epirubicin—stomach cancer	0.00026	0.000563	CcSEcCtD
Epoprostenol—Hypotension—Doxorubicin—stomach cancer	0.000259	0.00056	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000258	0.000559	CcSEcCtD
Epoprostenol—Fatigue—Epirubicin—stomach cancer	0.000258	0.000558	CcSEcCtD
Epoprostenol—Pain—Epirubicin—stomach cancer	0.000256	0.000554	CcSEcCtD
Epoprostenol—Constipation—Epirubicin—stomach cancer	0.000256	0.000554	CcSEcCtD
Epoprostenol—Nausea—Capecitabine—stomach cancer	0.000255	0.000552	CcSEcCtD
Epoprostenol—Urticaria—Methotrexate—stomach cancer	0.000254	0.00055	CcSEcCtD
Epoprostenol—Body temperature increased—Methotrexate—stomach cancer	0.000253	0.000547	CcSEcCtD
Epoprostenol—Abdominal pain—Methotrexate—stomach cancer	0.000253	0.000547	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000252	0.000546	CcSEcCtD
Epoprostenol—Insomnia—Doxorubicin—stomach cancer	0.00025	0.000542	CcSEcCtD
Epoprostenol—Paraesthesia—Doxorubicin—stomach cancer	0.000249	0.000538	CcSEcCtD
Epoprostenol—Dyspnoea—Doxorubicin—stomach cancer	0.000247	0.000534	CcSEcCtD
Epoprostenol—Somnolence—Doxorubicin—stomach cancer	0.000246	0.000533	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Epirubicin—stomach cancer	0.000245	0.000529	CcSEcCtD
Epoprostenol—Dyspepsia—Doxorubicin—stomach cancer	0.000244	0.000527	CcSEcCtD
Epoprostenol—Decreased appetite—Doxorubicin—stomach cancer	0.000241	0.000521	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000239	0.000517	CcSEcCtD
Epoprostenol—Fatigue—Doxorubicin—stomach cancer	0.000239	0.000517	CcSEcCtD
Epoprostenol—Urticaria—Epirubicin—stomach cancer	0.000238	0.000514	CcSEcCtD
Epoprostenol—Pain—Doxorubicin—stomach cancer	0.000237	0.000512	CcSEcCtD
Epoprostenol—Constipation—Doxorubicin—stomach cancer	0.000237	0.000512	CcSEcCtD
Epoprostenol—Abdominal pain—Epirubicin—stomach cancer	0.000237	0.000512	CcSEcCtD
Epoprostenol—Body temperature increased—Epirubicin—stomach cancer	0.000237	0.000512	CcSEcCtD
Epoprostenol—Hypersensitivity—Methotrexate—stomach cancer	0.000236	0.00051	CcSEcCtD
Epoprostenol—Asthenia—Methotrexate—stomach cancer	0.000229	0.000496	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000226	0.00049	CcSEcCtD
Epoprostenol—Pruritus—Methotrexate—stomach cancer	0.000226	0.00049	CcSEcCtD
Epoprostenol—Hypersensitivity—Epirubicin—stomach cancer	0.00022	0.000477	CcSEcCtD
Epoprostenol—Urticaria—Doxorubicin—stomach cancer	0.00022	0.000476	CcSEcCtD
Epoprostenol—Abdominal pain—Doxorubicin—stomach cancer	0.000219	0.000474	CcSEcCtD
Epoprostenol—Body temperature increased—Doxorubicin—stomach cancer	0.000219	0.000474	CcSEcCtD
Epoprostenol—Diarrhoea—Methotrexate—stomach cancer	0.000219	0.000473	CcSEcCtD
Epoprostenol—Asthenia—Epirubicin—stomach cancer	0.000215	0.000465	CcSEcCtD
Epoprostenol—Pruritus—Epirubicin—stomach cancer	0.000212	0.000458	CcSEcCtD
Epoprostenol—Dizziness—Methotrexate—stomach cancer	0.000211	0.000458	CcSEcCtD
Epoprostenol—Diarrhoea—Epirubicin—stomach cancer	0.000205	0.000443	CcSEcCtD
Epoprostenol—Hypersensitivity—Doxorubicin—stomach cancer	0.000204	0.000441	CcSEcCtD
Epoprostenol—Vomiting—Methotrexate—stomach cancer	0.000203	0.00044	CcSEcCtD
Epoprostenol—Rash—Methotrexate—stomach cancer	0.000202	0.000436	CcSEcCtD
Epoprostenol—Dermatitis—Methotrexate—stomach cancer	0.000201	0.000436	CcSEcCtD
Epoprostenol—Headache—Methotrexate—stomach cancer	0.0002	0.000433	CcSEcCtD
Epoprostenol—Asthenia—Doxorubicin—stomach cancer	0.000199	0.00043	CcSEcCtD
Epoprostenol—Dizziness—Epirubicin—stomach cancer	0.000198	0.000428	CcSEcCtD
Epoprostenol—Pruritus—Doxorubicin—stomach cancer	0.000196	0.000424	CcSEcCtD
Epoprostenol—Vomiting—Epirubicin—stomach cancer	0.00019	0.000412	CcSEcCtD
Epoprostenol—Nausea—Methotrexate—stomach cancer	0.00019	0.000411	CcSEcCtD
Epoprostenol—Diarrhoea—Doxorubicin—stomach cancer	0.000189	0.00041	CcSEcCtD
Epoprostenol—Rash—Epirubicin—stomach cancer	0.000189	0.000408	CcSEcCtD
Epoprostenol—Dermatitis—Epirubicin—stomach cancer	0.000189	0.000408	CcSEcCtD
Epoprostenol—Headache—Epirubicin—stomach cancer	0.000187	0.000406	CcSEcCtD
Epoprostenol—Dizziness—Doxorubicin—stomach cancer	0.000183	0.000396	CcSEcCtD
Epoprostenol—Nausea—Epirubicin—stomach cancer	0.000178	0.000385	CcSEcCtD
Epoprostenol—Vomiting—Doxorubicin—stomach cancer	0.000176	0.000381	CcSEcCtD
Epoprostenol—Rash—Doxorubicin—stomach cancer	0.000175	0.000378	CcSEcCtD
Epoprostenol—Dermatitis—Doxorubicin—stomach cancer	0.000174	0.000377	CcSEcCtD
Epoprostenol—Headache—Doxorubicin—stomach cancer	0.000173	0.000375	CcSEcCtD
Epoprostenol—Nausea—Doxorubicin—stomach cancer	0.000164	0.000356	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—IL6ST—stomach cancer	0.000111	0.000349	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000111	0.000346	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRB1—stomach cancer	0.00011	0.000343	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRB1—stomach cancer	0.00011	0.000343	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—MAPK3—stomach cancer	0.000106	0.00033	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6R—stomach cancer	0.000105	0.00033	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RPS6—stomach cancer	0.000105	0.000327	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RPS6—stomach cancer	0.000105	0.000327	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HBEGF—stomach cancer	0.000105	0.000327	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CAV1—stomach cancer	0.000104	0.000327	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—APOA1—stomach cancer	0.000104	0.000326	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000104	0.000326	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PRKCB—stomach cancer	0.000103	0.000322	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PRKCB—stomach cancer	0.000103	0.000322	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—stomach cancer	0.000103	0.000321	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6ST—stomach cancer	0.000103	0.000321	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6ST—stomach cancer	0.000103	0.000321	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GMPR2—stomach cancer	0.000101	0.000316	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—MAPK1—stomach cancer	0.0001	0.000314	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.98e-05	0.000312	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6R—stomach cancer	9.95e-05	0.000311	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—RHOA—stomach cancer	9.89e-05	0.000309	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SERPINE1—stomach cancer	9.88e-05	0.000309	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	9.75e-05	0.000305	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—MAPK3—stomach cancer	9.72e-05	0.000304	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRB2—stomach cancer	9.65e-05	0.000302	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	9.63e-05	0.000301	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HBEGF—stomach cancer	9.62e-05	0.000301	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HBEGF—stomach cancer	9.62e-05	0.000301	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—RHOA—stomach cancer	9.53e-05	0.000298	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—KRAS—stomach cancer	9.49e-05	0.000297	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PPP2R1A—stomach cancer	9.45e-05	0.000296	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS3—stomach cancer	9.43e-05	0.000295	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—MAPK1—stomach cancer	9.25e-05	0.000289	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SUCLG1—stomach cancer	9.23e-05	0.000289	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—IDH3B—stomach cancer	9.23e-05	0.000289	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARG—stomach cancer	9.18e-05	0.000287	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6R—stomach cancer	9.15e-05	0.000286	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6R—stomach cancer	9.15e-05	0.000286	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—RHOA—stomach cancer	9.1e-05	0.000285	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—RHOA—stomach cancer	9.1e-05	0.000285	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—RHOA—stomach cancer	8.98e-05	0.000281	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRB2—stomach cancer	8.88e-05	0.000278	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRB2—stomach cancer	8.88e-05	0.000278	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—ERBB2—stomach cancer	8.82e-05	0.000276	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SMAD4—stomach cancer	8.78e-05	0.000275	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—KRAS—stomach cancer	8.73e-05	0.000273	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—PIK3CA—stomach cancer	8.72e-05	0.000273	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PPP2R1A—stomach cancer	8.7e-05	0.000272	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PPP2R1A—stomach cancer	8.7e-05	0.000272	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL8—stomach cancer	8.68e-05	0.000272	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—stomach cancer	8.63e-05	0.00027	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NDUFV1—stomach cancer	8.58e-05	0.000269	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NDUFS1—stomach cancer	8.58e-05	0.000269	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—stomach cancer	8.43e-05	0.000264	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	8.39e-05	0.000262	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FYN—stomach cancer	8.33e-05	0.000261	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—RHOA—stomach cancer	8.27e-05	0.000259	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—RHOA—stomach cancer	8.27e-05	0.000259	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALB—stomach cancer	8.26e-05	0.000258	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CDKN1B—stomach cancer	8.17e-05	0.000256	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SMAD4—stomach cancer	8.08e-05	0.000253	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SMAD4—stomach cancer	8.08e-05	0.000253	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—HRAS—stomach cancer	8.07e-05	0.000252	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—PIK3CA—stomach cancer	8.02e-05	0.000251	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL8—stomach cancer	7.99e-05	0.00025	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL8—stomach cancer	7.99e-05	0.00025	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NOS3—stomach cancer	7.9e-05	0.000247	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL8—stomach cancer	7.89e-05	0.000247	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGFR2—stomach cancer	7.82e-05	0.000245	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—stomach cancer	7.76e-05	0.000243	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FYN—stomach cancer	7.67e-05	0.00024	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FYN—stomach cancer	7.67e-05	0.00024	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PGLS—stomach cancer	7.65e-05	0.000239	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BLVRB—stomach cancer	7.65e-05	0.000239	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CDKN1A—stomach cancer	7.54e-05	0.000236	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—HRAS—stomach cancer	7.42e-05	0.000232	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPAP2A—stomach cancer	7.3e-05	0.000228	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL8—stomach cancer	7.26e-05	0.000227	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL8—stomach cancer	7.26e-05	0.000227	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—stomach cancer	7.22e-05	0.000226	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGFR2—stomach cancer	7.2e-05	0.000225	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGFR2—stomach cancer	7.2e-05	0.000225	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IRS2—stomach cancer	7.16e-05	0.000224	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	7.02e-05	0.00022	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CAV1—stomach cancer	6.95e-05	0.000217	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APOA1—stomach cancer	6.93e-05	0.000217	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—STAT3—stomach cancer	6.73e-05	0.00021	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRKCB—stomach cancer	6.61e-05	0.000207	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IRS2—stomach cancer	6.59e-05	0.000206	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IRS2—stomach cancer	6.59e-05	0.000206	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6ST—stomach cancer	6.58e-05	0.000206	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FBP1—stomach cancer	6.51e-05	0.000203	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NDUFA2—stomach cancer	6.51e-05	0.000203	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CKB—stomach cancer	6.51e-05	0.000203	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CA1—stomach cancer	6.51e-05	0.000203	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MAPK3—stomach cancer	6.43e-05	0.000201	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CAV1—stomach cancer	6.39e-05	0.0002	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CAV1—stomach cancer	6.39e-05	0.0002	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOA1—stomach cancer	6.38e-05	0.0002	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOA1—stomach cancer	6.38e-05	0.0002	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APC—stomach cancer	6.33e-05	0.000198	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MYC—stomach cancer	6.25e-05	0.000196	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLIN2—stomach cancer	6.12e-05	0.000191	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MAPK1—stomach cancer	6.12e-05	0.000191	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EGFR—stomach cancer	6.11e-05	0.000191	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRKCB—stomach cancer	6.08e-05	0.00019	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRKCB—stomach cancer	6.08e-05	0.00019	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6ST—stomach cancer	6.06e-05	0.00019	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6ST—stomach cancer	6.06e-05	0.00019	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—MAPK3—stomach cancer	6.06e-05	0.00019	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CA2—stomach cancer	5.95e-05	0.000186	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6R—stomach cancer	5.87e-05	0.000184	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APC—stomach cancer	5.82e-05	0.000182	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APC—stomach cancer	5.82e-05	0.000182	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PGAM1—stomach cancer	5.8e-05	0.000181	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NT5E—stomach cancer	5.8e-05	0.000181	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—KRAS—stomach cancer	5.78e-05	0.000181	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—MAPK1—stomach cancer	5.77e-05	0.00018	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—EGFR—stomach cancer	5.76e-05	0.00018	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—MAPK3—stomach cancer	5.58e-05	0.000174	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—MAPK3—stomach cancer	5.58e-05	0.000174	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDH7A1—stomach cancer	5.53e-05	0.000173	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLCE1—stomach cancer	5.53e-05	0.000173	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PIK3CA—stomach cancer	5.51e-05	0.000172	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SERPINE1—stomach cancer	5.5e-05	0.000172	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—KRAS—stomach cancer	5.45e-05	0.00017	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6R—stomach cancer	5.41e-05	0.000169	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6R—stomach cancer	5.41e-05	0.000169	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RHOA—stomach cancer	5.31e-05	0.000166	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PIK3CA—stomach cancer	5.31e-05	0.000166	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—MAPK1—stomach cancer	5.31e-05	0.000166	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—MAPK1—stomach cancer	5.31e-05	0.000166	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—EGFR—stomach cancer	5.3e-05	0.000166	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—EGFR—stomach cancer	5.3e-05	0.000166	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—UMPS—stomach cancer	5.3e-05	0.000166	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—stomach cancer	5.25e-05	0.000164	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PIK3CA—stomach cancer	5.07e-05	0.000159	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PIK3CA—stomach cancer	5.07e-05	0.000159	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SERPINE1—stomach cancer	5.06e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SERPINE1—stomach cancer	5.06e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—KRAS—stomach cancer	5.01e-05	0.000157	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—KRAS—stomach cancer	5.01e-05	0.000157	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PIK3CA—stomach cancer	5e-05	0.000156	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PDHA1—stomach cancer	4.93e-05	0.000154	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ECHS1—stomach cancer	4.93e-05	0.000154	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ERBB2—stomach cancer	4.91e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—HRAS—stomach cancer	4.91e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RHOA—stomach cancer	4.88e-05	0.000153	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RHOA—stomach cancer	4.88e-05	0.000153	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—stomach cancer	4.83e-05	0.000151	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—stomach cancer	4.83e-05	0.000151	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—stomach cancer	4.7e-05	0.000147	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—stomach cancer	4.66e-05	0.000146	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TYMP—stomach cancer	4.64e-05	0.000145	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FADS1—stomach cancer	4.64e-05	0.000145	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HRAS—stomach cancer	4.63e-05	0.000145	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PIK3CA—stomach cancer	4.6e-05	0.000144	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PIK3CA—stomach cancer	4.6e-05	0.000144	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDKN1B—stomach cancer	4.55e-05	0.000142	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ERBB2—stomach cancer	4.52e-05	0.000141	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ERBB2—stomach cancer	4.52e-05	0.000141	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3CA—stomach cancer	4.44e-05	0.000139	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—stomach cancer	4.43e-05	0.000139	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SREBF2—stomach cancer	4.34e-05	0.000136	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCND1—stomach cancer	4.34e-05	0.000136	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—JUN—stomach cancer	4.33e-05	0.000135	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—RORA—stomach cancer	4.29e-05	0.000134	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—stomach cancer	4.29e-05	0.000134	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—stomach cancer	4.29e-05	0.000134	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HRAS—stomach cancer	4.26e-05	0.000133	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HRAS—stomach cancer	4.26e-05	0.000133	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—stomach cancer	4.21e-05	0.000132	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDKN1A—stomach cancer	4.2e-05	0.000131	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDKN1B—stomach cancer	4.19e-05	0.000131	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDKN1B—stomach cancer	4.19e-05	0.000131	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK8—stomach cancer	4.1e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—stomach cancer	4.08e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—stomach cancer	4.08e-05	0.000128	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDOB—stomach cancer	4.02e-05	0.000126	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCND1—stomach cancer	3.99e-05	0.000125	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCND1—stomach cancer	3.99e-05	0.000125	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—JUN—stomach cancer	3.99e-05	0.000125	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—JUN—stomach cancer	3.99e-05	0.000125	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—stomach cancer	3.88e-05	0.000121	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—stomach cancer	3.88e-05	0.000121	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDKN1A—stomach cancer	3.86e-05	0.000121	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDKN1A—stomach cancer	3.86e-05	0.000121	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.79e-05	0.000119	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—stomach cancer	3.78e-05	0.000118	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.78e-05	0.000118	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK8—stomach cancer	3.77e-05	0.000118	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK8—stomach cancer	3.77e-05	0.000118	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STAT3—stomach cancer	3.75e-05	0.000117	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX5—stomach cancer	3.74e-05	0.000117	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DPYD—stomach cancer	3.68e-05	0.000115	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK3—stomach cancer	3.58e-05	0.000112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—stomach cancer	3.48e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—stomach cancer	3.48e-05	0.000109	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MYC—stomach cancer	3.48e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT3—stomach cancer	3.45e-05	0.000108	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STAT3—stomach cancer	3.45e-05	0.000108	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK1—stomach cancer	3.41e-05	0.000107	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EGFR—stomach cancer	3.41e-05	0.000107	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.33e-05	0.000104	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK3—stomach cancer	3.29e-05	0.000103	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK3—stomach cancer	3.29e-05	0.000103	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTT1—stomach cancer	3.25e-05	0.000102	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—KRAS—stomach cancer	3.22e-05	0.000101	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2A6—stomach cancer	3.21e-05	0.000101	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MYC—stomach cancer	3.2e-05	0.0001	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MYC—stomach cancer	3.2e-05	0.0001	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK1—stomach cancer	3.13e-05	9.8e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK1—stomach cancer	3.13e-05	9.8e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EGFR—stomach cancer	3.13e-05	9.8e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EGFR—stomach cancer	3.13e-05	9.8e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKR1C3—stomach cancer	3.13e-05	9.78e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ENO1—stomach cancer	3.05e-05	9.53e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3e-05	9.37e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KRAS—stomach cancer	2.96e-05	9.26e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KRAS—stomach cancer	2.96e-05	9.26e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CA—stomach cancer	2.96e-05	9.24e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—stomach cancer	2.86e-05	8.94e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HRAS—stomach cancer	2.73e-05	8.55e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CA—stomach cancer	2.72e-05	8.51e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CA—stomach cancer	2.72e-05	8.51e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CD44—stomach cancer	2.7e-05	8.45e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—stomach cancer	2.63e-05	8.23e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—stomach cancer	2.63e-05	8.23e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.62e-05	8.2e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—stomach cancer	2.62e-05	8.19e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HRAS—stomach cancer	2.52e-05	7.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HRAS—stomach cancer	2.52e-05	7.87e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—stomach cancer	2.41e-05	7.53e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—stomach cancer	2.41e-05	7.53e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPP2R1A—stomach cancer	2.3e-05	7.18e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTP1—stomach cancer	2.25e-05	7.05e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMOX1—stomach cancer	2.22e-05	6.95e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TYMS—stomach cancer	2.09e-05	6.55e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTM1—stomach cancer	2.07e-05	6.48e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ERCC2—stomach cancer	1.95e-05	6.09e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—stomach cancer	1.83e-05	5.72e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAV1—stomach cancer	1.69e-05	5.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOA1—stomach cancer	1.68e-05	5.27e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.61e-05	5.04e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—stomach cancer	1.48e-05	4.64e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—stomach cancer	1.33e-05	4.17e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—stomach cancer	1.28e-05	3.99e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—stomach cancer	1.17e-05	3.65e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CA—stomach cancer	7.18e-06	2.25e-05	CbGpPWpGaD
